03.03.2014 • News

DSM Resumes Share Buyback Plan

Dutch chemical producer DSM began repurchasing 2,500,000 ordinary shares, on 27 February 2014 to cover its commitments under existing management and personnel option plans. Based on the share's closing price in Amsterdam on Feb. 26, the buyback would be worth around €120 million.

The company said the share repurchase program - the second and final part of a program to repurchase a total of 5 million shares announced in September 2013 - is expected to continue into Q2 2014. The first tranche was completed in January, with 2,500,000 ordinary shares repurchased for a total consideration of 139 million.

Under a Discretionary Management Agreement signed with the bank executing the repurchase, the price will be based on the daily VWAP (Volume Weighted Average Price). On average, the volumes to be repurchased will represent 5% of the daily trading volume on Euronext Amsterdam.

Separately, DSM said it has successfully issued a €500 million 2.375% bond, due in 2024, as part of its debt reduction plan. The proceeds will be used to refinance the €500 million bond maturing on 17 March 2014.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Virtual Event

Outsourced Biomanufacturing
Strategic Outsourcing in Biopharmaceuticals

Outsourced Biomanufacturing

April 22, 2026 | Join biopharma professionals, CDMO leaders, and supply chain innovators for a virtual event exploring the future of outsourced biomanufacturing.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.